Cite
HARVARD Citation
Eckard, S. et al. (n.d.). 692 AMV564, a clinically active T cell engager, induces a target-dependent adaptive immune response. Journal for immunotherapy of cancer. pp. A733-A734. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Eckard, S. et al. (n.d.). 692 AMV564, a clinically active T cell engager, induces a target-dependent adaptive immune response. Journal for immunotherapy of cancer. pp. A733-A734. [Online].